Search

Pucotenlimab

[A257296] It is being investigated in other cancers. … Pucotenlimab is a recombinant humanized anti-PD-1 monoclonal antibody. It received its first global approval in China in July 2022 for the treatment of solid tumours.

Tezacitabine

A synthetic purine nucleoside analogue with potential antineoplastic activity.

Rabies virus inactivated antigen, B

Inactivated rabies virus antigen B is a component of rabies vaccines used for pre- and post-exposure prophylaxis against rabies.[L12795]

Tetrahydrofolic acid

It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a soluble coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. … Tetrahydrofolic acid is a folic acid derivative that is produced from dihydrofolic acid after conversion by dihydrofolate reductase.

BCc1

BCc1 is a nanomedicine that demonstrated potent anticancer effects in both in vitro and in vivo studies.

Meclofenoxate

Pimobendan

Ammonium tetrathiomolybdate

Tricetin

Imiglucerase

Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase.